Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· SS. 2408 (116th)referred
United States · United States Congress · 31 July 2019
Telehealth Across State Lines Act of 2019 This bill requires the Department of Health and Human Services, in consultation with a range of stakeholders, to issue guidance for uniform best practices for the delivery of telehealth services. The bill also establishes a grant program to expand access to telehealth services in rural areas and revises the duties of the Center for Medicare and Medicaid Innovation to incentivize the adoption of telehealth services.
Bill· SS. 2406 (116th)referred
United States · United States Congress · 31 July 2019
Rural America Health Corps Act This bill requires the Health Resources and Services Administration to establish a demonstration project under the National Health Service Corps Loan Repayment Program to increase the number of health care providers in rural areas. Specifically, eligible participants who agree to serve for 5 years in such a rural area may receive up to $25,000 in loan repayments for each year of service.
Bill· SS. 2402 (116th)referred
United States · United States Congress · 31 July 2019
Crude Oil Advance Tracking Act or the COAT Act This bill addresses safety concerns regarding railroad carriers transporting Class 3 flammable liquids (e.g., crude oil) and other high hazardous liquids or gases. Specifically, the bill requires railroad carriers transporting Class 3 flammable liquids to (1) share information regarding such shipments with state emergency responders, including the number of gallons of the liquids; and (2) include in each annual report information regarding their ability to pay all costs of cleaning up a reasonable, worst-case spill; provides grants for local communities to develop, improve, and implement emergency plans that address responses to high-hazard rail shipments; and provides financial assistance for local projects, activities, and personnel that mitigate the impacts of, and public health or environmental risks associated with, the transport of flammable liquids or gases by rail.
Bill· SS. 2400 (116th)referred
United States · United States Congress · 31 July 2019
Expanding Cannabis Research and Information Act This bill changes marijuana from a Schedule I to a Schedule III controlled substance, which allows it to be dispensed, subject to certain limitations, for accepted medical uses with a written or oral prescription. The bill also requires the National Institutes of Health (NIH) to collaborate with specified agencies to develop a national cannabis research agenda that must address (1) the therapeutic benefits of cannabis, (2) how it effects specified populations, (3) its long-term effects, (4) clinically appropriate methods to deliver it to the body, and (5) other public safety considerations. Additionally, the bill directs NIH to designate centers of excellence in cannabis research at institutions of higher education to conduct interdisciplinary research about biomedical, behavioral, and social issued related to cannabis. Further, the Centers for Disease Control and Prevention must work with other agencies to collect population-wide data about cannabis use, including (1) demographic factors, (2) health outcomes, (3) health care utilization rates, (4) product variety, (5) delivery methods, and (6) other relevant health information.
Bill· SS. 2387 (116th)referred
United States · United States Congress · 31 July 2019
We Protect American Investment in Drugs Act or the We PAID Act This bill limits the price of certain prescription drugs that rely on patents developed with federal support. The bill requires the Department of Health and Human Services to contract with the National Academy of Medicine to conduct a study for determining the reasonableness of the price of such prescription drugs. The bill also establishes the Drug Affordability and Access Committee, which must use the study to develop a methodology and then determine whether the price of each applicable drug is reasonable after the drug enters the market. Further, the bill establishes certain pricing requirements for such prescription drugs. First, the manufacturer must submit to the committee the list and retail prices for the drug as well as specified expenditure information. Second, after a drug is on the market for one year, the manufacture must set the drug’s list price at no more than the committee’s reasonable price determination. Third, subsequent price increases are capped at the annual percentage change in the medical care consumer price index for prescription drugs. The penalties for noncompliance with these requirements include expiration of marketing exclusivity, fines, and prohibitions on entering licensing agreements for the applicable drug. Additionally, the bill revises the patent application requirements for drugs to include the disclosure of specified federal grants.
Bill· SS. 2379 (116th)referred
United States · United States Congress · 31 July 2019
Medicaid Patient Abuse Prevention Act This bill allows state Medicaid fraud control units to investigate complaints of patient abuse or neglect in additional settings. Specifically, the bill allows a unit to review complaints regarding Medicaid patients who are in noninstitutional or other settings. Currently, such units may review complaints regarding patients who are in Medicaid-funded health care facilities or certain board-and-care facilities.
Bill· SS. 2377 (116th)referred
United States · United States Congress · 31 July 2019
Medicaid Accountability Act This bill establishes and expands certain requirements relating to Medicaid asset verification programs and other eligibility determinations. Specifically, the bill requires state Medicaid programs to verify the assets of all Medicaid applicants and recipients for purposes of determining Medicaid eligibility, rather than only of applicants or recipients who are aged, blind, or disabled. The bill also requires U.S. territories to implement asset verification programs. Such requirements must be fully implemented by FY2024. The bill also requires state Medicaid programs to apply a resource eligibility test whenever an income eligibility determination is required, based on resource limitations under the Supplemental Security Income program (currently, states are prohibited from using resource tests).
Bill· SS. 2373 (116th)referred
United States · United States Congress · 31 July 2019
Rural Maternal and Obstetric Modernization of Services Act or the Rural MOMS Act This bill expands initiatives to address maternal health in rural areas. The bill provides funding for the Health Resources and Services Administration (HRSA) to establish rural obstetric networks for improving outcomes in birth and maternal morbidity. Specifically, these networks must (1) connect individuals with care providers, (2) identify successful maternal-care models, (3) facilitate collaboration among rural providers, (4) provide training and guidance, (5) collaborate with academic institutions that have regional expertise, and (6) measure and address inequities in birth outcomes among rural residents. HRSA also must award five-year demonstration program grants to (1) train physicians, medical residents, and other practitioners to provide maternal and obstetric services in rural communities; and (2) support academic programs that develop or provide training to improve maternal care in rural areas. Further, the bill adds maternal-health services as part of the telehealth network and telehealth resource-centers grant programs. The bill also makes a series of changes to the research and reporting requirements of the Department of Health and Human Services and the Government Accountability Office with respect to data on maternal-health outcomes.
Resolution· SRESS.Res. 300 (116th)passed
United States · United States Congress · 31 July 2019
This resolution expresses support for National Public Health week, recognizes the efforts of public health professionals, and encourages strengthening the public health system.
Resolution· SRESS.Res. 299 (116th)referred
United States · United States Congress · 31 July 2019
This resolution designates the first week of August 2019 as World Breastfeeding Week, designates August 2019 as National Breastfeeding Month, and expresses support for policies and funding to ensure that all mothers who choose to breastfeed can access a full range of supports.
Bill· HRH.R. 4131 (116th)referred
United States · United States Congress · 30 July 2019
Improving Access to Remote Behavioral Health Treatment Act of 2019 This bill directs the Drug Enforcement Administration to register certain community mental health centers to administer controlled substances via telemedicine.
Bill· HRH.R. 4137 (116th)referred
United States · United States Congress · 30 July 2019
Jennifer Kepner Healthcare for Open air burn Pit Exposure Act or the Jennifer Kepner HOPE Act This bill extends eligibility for hospital, nursing home, and medical services from the Department of Veterans Affairs to veterans who were exposed to burn pits (areas used for burning solid waste in open air without equipment).
Bill· HRH.R. 4138 (116th)referred
United States · United States Congress · 30 July 2019
State Veterans Home Inspection Simplification Act This bill alters certain requirements relating to inspection and certification of Medicare skilled nursing facilities that are also state veterans homes. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to treat state veterans homes that are inspected and determined to meet applicable standards set by the Department of Veterans Affairs (VA) as also meeting applicable standards for skilled nursing facilities under Medicare. The CMS must also use VA inspection reports for such facilities in lieu of state inspection reports for purposes of the Nursing Home Compare website.
Bill· HRH.R. 4129 (116th)referred
United States · United States Congress · 30 July 2019
Medicare Demonstration of Coverage for Low Vision Devices Act of 2019 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. The bill defines low-vision device to mean a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2020 and each of the next four fiscal years for the CMS to carry out the project.
Resolution· HRESH.Res. 532 (116th)referred
United States · United States Congress · 30 July 2019
This resolution expresses the sense of the House of Representatives that Medicare should be made available to all Americans and that certain steps could be taken to reach this goal.
Bill· HRH.R. 4111 (116th)referred
United States · United States Congress · 30 July 2019
Combating Meth and Cocaine Act This bill authorizes the Substance Abuse and Mental Health Services Administration to award grants to states for the treatment and prevention of opioid-use disorders. Funds may be used for activities including education, treatment, and medical screenings related to opioid-use disorders, as well as for referrals to behavioral health services and recovery support. Grants also may be used to prevent or treat cocaine- or methamphetamine-use disorders.
Bill· HRH.R. 4106 (116th)referred
United States · United States Congress · 30 July 2019
Responsibility in Drug Advertising Act of 2019 This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
Bill· HRH.R. 4100 (116th)referred
United States · United States Congress · 30 July 2019
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019 This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
Bill· SS. 2326 (116th)referred
United States · United States Congress · 30 July 2019
New Opportunities for Value that Extend Lives Act of 2019 or the NOVEL Act of 2019 This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.
Bill· SS. 2308 (116th)referred
United States · United States Congress · 29 July 2019
Patients First Act of 2019 This bill requires the National Institutes of Health (NIH) to support stem cell research. Specifically, the NIH must conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions. However, such techniques must not involve (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill. The NIH must also report on peer-reviewed stem cell research proposals that were not funded.
Bill· SS. 2305 (116th)referred
United States · United States Congress · 29 July 2019
Humane Correctional Health Care Act This bill allows states to cover inmates of public institutions under Medicaid. The Government Accountability Office must report on specified information relating to the health of inmates and the effects of Medicaid coverage.
Bill· SS. 2304 (116th)referred
United States · United States Congress · 29 July 2019
Strategies To Address Antibiotic Resistance Act or the STAAR Act This bill expands various initiatives to address antibiotic resistance. The bill reestablishes the interagency Antimicrobial Resistance Task Force to coordinate and develop efforts addressing antibiotic resistance. The Department of Health and Human Services must encourage health care facilities to implement antimicrobial stewardship programs to evaluate and improve the use of antimicrobial drugs. The bill also requires the Centers for Disease Control and Prevention (CDC) to use the National Healthcare Safety Network to collect and report data about the usage of antibiotic drugs, changes in resistance to such drugs, and other trends impacting patient outcomes. Additionally, the bill increases nationwide efforts to monitor, research, and prevent the spread of infection from resistant organisms by establishing the Antibiotic Resistance Surveillance and Laboratory Network in at least seven geographic regions, establishing the Clinical Trials Network on Antibacterial Resistance to conduct clinical research, and requiring the CDC to collaborate with state and local agencies to support health care facilities that focus on preventing the spread of antibiotic-resistant bacteria.
Bill· HRH.R. 4078 (116th)referred
United States · United States Congress · 25 July 2019
EARLY Act Reauthorization of 2019 This bill reauthorizes through FY2024 programs that raise public awareness about breast health, educate health care providers to encourage early detection of breast cancer, and provide support for young women diagnosed with breast cancer.
Bill· HRH.R. 3995 (116th)referred
United States · United States Congress · 25 July 2019
Veterans, Employees, and Taxpayers Protection Act of 2019 or the VET Protection Act of 2019 This bill directs the Department of Veterans Affairs (VA) to track the use of official time by VA employees without using estimates or time ranges. Official time is time granted to an employee under federal labor-management relations provisions to perform representational or consultative functions, during which the employee would otherwise be in a duty status. The bill prohibits (1) a VA employee from using official time to carry out political or lobbying activities; (2) specified health care employees, probationary employees, or employees above a certain salary level from using official time for any purpose without a waiver; and (3) any VA employee from spending more than 25% of the time such employee would otherwise be in a duty status on official time without a waiver. The authority provided to the VA to grant a waiver shall not be subject to bargaining, and the exercise of (or failure to exercise) such authority shall not be an unfair labor practice. An exclusive bargaining agreement shall allow a VA employee to terminate a voluntary dues allotment at any time. A covered VA employee shall serve a two-year probationary period, after which the employee's supervisor shall determine within 90 days whether or not the appointment is permanent. A covered employee is any individual appointed to a permanent position within the competitive service or the Senior Executive Service and does not include specified health care practitioners.
Bill· HRH.R. 4063 (116th)referred
United States · United States Congress · 25 July 2019
Medicare Adult Day Services Act of 2019 This bill provides for Medicare coverage and payment of certified adult day services that meet specified requirements. Among other things, services must be furnished by an authorized home- and community-based services provider at a certified adult day services center and in accordance with a physician-approved plan. Covered services include nursing services, physical therapy, nutritional meals, physical activities, and medication-management programs.
Bill· HRH.R. 4056 (116th)referred
United States · United States Congress · 25 July 2019
Medicare Audiologist Access and Services Act of 2019 This bill provides for Medicare coverage of certain audiologist services. Specifically, the bill expands coverage to include diagnostic and treatment services that are furnished by audiologists and that would otherwise be covered if provided by a physician, including incidental services, regardless of whether such services are provided pursuant to a referral from, or under the supervision of, a physician or other health care practitioner.
Bill· HRH.R. 4013 (116th)referred
United States · United States Congress · 25 July 2019
Telehealth Innovation and Improvement Act of 2019 This bill establishes (1) a telehealth service model, and (2) Medicare payment rules with respect to certain services tested under the model. The Centers for Medicare & Medicaid Services (CMS) shall test Medicare coverage of expanded telehealth services, as defined by the bill, in conjunction with existing models that test the use of accountable care organizations, bundled payments, and other coordinated care models under Medicare. The CMS must (1) establish a methodology for determining the amounts of payment for such services, and (2) provide for evaluations of the service model by an independent entity. The CMS shall expand the application of a service tested under the model if (1) the required evaluation demonstrates that the service either reduced Medicare spending without reducing the quality of care or improved the quality of care without increasing spending, and (2) the Chief Actuary of the CMS certifies that such expansion would reduce net program spending. A service that meets these requirements is defined by the bill as a certified enhanced telehealth service . Medicare payment for a certified enhanced telehealth service shall equal 80% of the lesser of (1) the actual charge for the service, or (2) the amount determined using the payment methodology established under the test model. The CMS shall pay for such services without regard to a Medicare beneficiary's location or area of residence.
Bill· HRH.R. 4010 (116th)referred
United States · United States Congress · 25 July 2019
Emergency Access to Insulin Act of 2019 This bill reduces the marketing exclusivity period for biological drug products from 12 to 7 years and establishes policies and programs designed to increase access to prescription insulin. Specifically, the bill requires the Centers for Disease Control and Prevention to award grants to states to create insulin card programs, which provide uninsured or underinsured individuals with insulin at no cost for specified time periods. Payments for insulin prescriptions made through the program must count toward an underinsured individual’s health plan deductible. Further, the Department of Health and Human Services (HHS) must collect annual fees from insulin manufacturers, based on each manufacturer’s market share, equal to the total estimated expenditures under the insulin grants program. Subject to certain exceptions, the bill also establishes an excise tax on insulin manufacturers when the price of an insulin product spikes. The tax amount is a specified percentage of the revenue a manufacturer received as a result of the price spike. The tax amount increases in tiers based on the percentage of the price spike for that product.
Bill· HRH.R. 4004 (116th)referred
United States · United States Congress · 25 July 2019
Social Determinants Accelerator Act of 2019 This bill establishes the Social Determinants Accelerator Interagency Council and provides funds for the council to (1) assist the Centers for Medicare & Medicaid Services (CMS) in awarding specified grants, (2) increase coordination among health and social service programs, and (3) provide program evaluation guidance and technical assistance to increase the impact of social service programs. Specifically, the bill provides funds for the CMS to award up to 25 grants to state, local, or tribal health or human services agencies for the development of social determinants accelerator plans that address at least one health and one social outcome for a specified target population.
Bill· HRH.R. 3984 (116th)referred
United States · United States Congress · 25 July 2019
Health Care Safety Net Enhancement Act of 2019 This bill extends civil liability protections to physicians and physician groups that provide emergency or post-stabilization services in Medicare-participating hospitals.
Bill· HRH.R. 3974 (116th)referred
United States · United States Congress · 25 July 2019
Prescription Drug Monitoring Act of 2019 This bill expands the notification and reporting requirements with respect to potentially addictive prescription drugs for states receiving funds for a Prescription Drug Monitoring Program (PDMP). Dispensers of these drugs, which includes substances listed in schedule II, III, or IV of the Controlled Substances Act, must consult with the PDMP before starting treatment involving such drugs and report each prescription of such drugs to the PDMP within 24 hours. The state agency administering a PDMP must analyze reported data for patterns of controlled substance misuse or abuse and provide certain information to law enforcement, the public, and other states.
Bill· HRH.R. 3965 (116th)referred
United States · United States Congress · 25 July 2019
Hospital Price Transparency and Disclosure Act This bill specifies the format that hospitals must disclose the standard charges for items and services by requiring them to submit such charges to the Centers for Medicare & Medicaid Services (CMS) and requiring the CMS to post the charges on its website.
Bill· HRH.R. 4040 (116th)referred
United States · United States Congress · 25 July 2019
Protecting Access to Spinal Surgeries Act This bill extends an exception to the application of site-neutral payment rates under the Medicare inpatient prospective payment system. Currently, certain long-term care hospitals that primarily treat spinal cord injuries are excluded from such payment rates through FY2019 if they meet certain other criteria (e.g., a significant number of discharges of out-of-state patients in FY2014). The bill extends this exception through FY2024.
Bill· HRH.R. 4025 (116th)referred
United States · United States Congress · 25 July 2019
Mental Health in Schools Excellence Program Act of 2019 This bill establishes a program to expand the mental-health services workforce in schools. Specifically, the bill requires the Department of Education to contract with graduate institutions to pay a share of the cost of attendance for graduate students pursuing careers in the school-based mental-health profession (e.g., school counselor).
Bill· HRH.R. 4019 (116th)referred
United States · United States Congress · 25 July 2019
Smoke-Free Schools Act of 2019 This bill prohibits the use of any tobacco product (e.g., electronic nicotine delivery systems such as e-cigarettes) in an indoor facility that is regularly used for children's services, including health care, day care, early development, education, or library services. Current law prohibits smoking in such facilities.
Bill· SS. 2296 (116th)referred
United States · United States Congress · 25 July 2019
Pregnancy Assistance Act of 2019 This bill reauthorizes through FY2024 the Pregnancy Assistance Fund program, which awards grants to states for a range of support services for expectant and parenting teens, women, fathers, and their families. Such services include those related to personal health, child health, parenting, education, and employment.
Bill· HRH.R. 3935 (116th)referred
United States · United States Congress · 24 July 2019
Protecting Patients Transportation to Care Act This bill provides statutory authority for the requirement that state Medicaid programs cover nonemergency transportation to medically necessary services. The bill also requires programs, as a condition of federal payment for such transportation services, to have a prior authorization or utilization management requirement for such services.
Bill· HRH.R. 3942 (116th)open
United States · United States Congress · 24 July 2019
Preventing Online Sales of E-Cigarettes to Children Act This bill revises requirements regarding the sale and delivery of electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens). Specifically, the bill subjects the sale and delivery of these systems to certain requirements, including tax, licensing, and labeling requirements; prohibits the sale and delivery of these systems to anyone under the legal age to purchase tobacco products; and requires the U.S. Postal Service to implement regulations to prohibit the mailing of these systems. The bill does not apply to products approved by the Food and Drug Administration for tobacco cessation or any other therapeutic purposes.
Bill· HRH.R. 3947 (116th)referred
United States · United States Congress · 24 July 2019
Competition Prescription Act of 2019 This bill revises various requirements related to the development, production, and sale of prescription drugs and biological products. First, the bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved product if the license holder has declined to make available sufficient quantities of the approved product for the developer's testing. The bill also requires the Food and Drug Administration (FDA) to establish a process for developers of generic complex drugs to request and receive expedited development and priority review. Further, upon request by a drug sponsor, a drug that treats a life-threatening disease or condition must be designated for expedited review if there are fewer than three drugs currently available for such treatment. States are prohibited from placing restrictions on dispensing substitute biological products that have been determined to be interchangeable with another product by the FDA. Additionally, the bill prohibits sponsors of Medicare Part D prescription drug plans from reducing a payment to a pharmacy after a claim without defect has been submitted by such pharmacy. The bill establishes requirements for pricing standards for pharmacy benefits managers under Medicare and other federal prescription drug benefits programs. Starting in 2025, the bill removes the cap on rebates paid by manufacturers of outpatient prescription drugs under Medicaid. Further, the bill requires the publication of specified information regarding licensed biological products, exempts from antitrust prohibitions specified drug-price negotiation strategies, and establishes a Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.
Bill· HRH.R. 3953 (116th)referred
United States · United States Congress · 24 July 2019
Supporting Positive Outcomes After Release Act This bill expands certain requirements relating to the eligibility of inmates of public institutions for Medicaid. Currently, state Medicaid programs (1) may suspend, but not terminate, a juvenile's Medicaid eligibility while the juvenile is an inmate; and (2) must restore coverage or determine a juvenile's eligibility, as applicable, upon the juvenile's release. The bill extends these provisions to all inmates of public institutions, regardless of age.
Bill· HRH.R. 3929 (116th)referred
United States · United States Congress · 24 July 2019
Greater Access and Independence through Nonvisual Access Technology Act of 2019 or the GAIN Act This bill requires the Architectural and Transportation Barriers Compliance Board (Access Board) to establish access standards for home (1) medical devices, (2) appliances, and (3) exercise equipment that allow blind consumers to effectively use such products.
Bill· HRH.R. 3927 (116th)referred
United States · United States Congress · 24 July 2019
PDMPs Help Patients Act of 2019 This bill directs the Department of Health and Human Services (HHS) to establish a grant program to test the feasibility of integrating substance use disorder and behavioral health treatment locator tools into prescription drug monitoring programs. HHS may award grants to up to five states.
Resolution· HCONRESH.Con.Res. 55 (116th)referred
United States · United States Congress · 24 July 2019
This concurrent resolution expresses the sense of Congress that (1) the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; (2) the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; (3) the final rule by the CMS published in the Federal Register on May 10, 2019, makes substantial progress in improving drug pricing transparency; and (4) such rule should be enacted into law.
Bill· SS. 2255 (116th)referred
United States · United States Congress · 24 July 2019
Supporting Positive Outcomes After Release Act This bill expands certain requirements relating to the eligibility of inmates of public institutions for Medicaid. Currently, state Medicaid programs (1) may suspend, but not terminate, a juvenile's Medicaid eligibility while the juvenile is an inmate; and (2) must restore coverage or determine a juvenile's eligibility, as applicable, upon the juvenile's release. The bill extends these provisions to all inmates of public institutions, regardless of age.
Bill· SS. 2252 (116th)referred
United States · United States Congress · 24 July 2019
Empowering States to Address Drug Costs Act This bill expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.
Bill· SS. 2247 (116th)referred
United States · United States Congress · 24 July 2019
Phair Relief Act of 2019 This bill establishes and otherwise modifies requirements for pharmacy benefit managers (PBMs), particularly with respect to the disclosure of certain drug pricing information. Among other things, the bill (1) requires PBMs to pass on a minimum percentage of negotiated rebates, discounts, or price concessions to plan sponsors; (2) temporarily requires negotiated prices for covered drugs under the Medicare prescription drug benefit to be provided at the point-of-sale; and (3) requires the Centers for Medicare & Medicaid Services to establish certain quality measures for determining pharmacy incentive payments.
Bill· SS. 2246 (116th)referred
United States · United States Congress · 24 July 2019
Allergy Testing Access Act of 2019 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
Bill· SS. 2244 (116th)referred
United States · United States Congress · 24 July 2019
Modernizing Eligible Treatment centers for Healing Addiction Act of 2019 or the METH Addiction Act This bill directs the Drug Enforcement Administration to register certain community addiction-treatment facilities and community mental-health centers to administer controlled substances via telemedicine.
Bill· HRH.R. 3906 (116th)referred
United States · United States Congress · 23 July 2019
Detention Oversight, Not Expansion Act or the DONE Act This bill prohibits the Department of Homeland Security (DHS) from using any federal funds to construct or expand immigration detention facilities and requires additional oversight of such facilities. The DHS Inspector General shall conduct various oversight activities into immigration detention facilities, including (1) periodic unannounced inspections; (2) audits to ensure compliance with various legal requirements; and (3) investigations into issues such as deaths in custody, detainee access to medical and mental health care, and sexual assault and harassment. DHS may not continue a contract with any facility deemed less than adequate in two of the most recent inspector general inspections, audits, or investigations. The Office for Civil Rights and Civil Liberties within DHS shall (1) investigate civil rights and civil liberties complaints in immigration detention facilities, and (2) periodically release on a public website data about such complaints and investigations. The bill requires various reports to Congress, including a DHS plan for decreasing the number of immigration detention beds and implementing community-based alternatives to detention.
Bill· HRH.R. 3925 (116th)referred
United States · United States Congress · 23 July 2019
Reducing Barriers to Substance Use Treatment Act This bill prohibits state Medicaid programs from imposing any utilization control policies, including prior authorization requirements, with respect to medication-assisted treatment for opioid-use disorders.